Spots Global Cancer Trial Database for pegfilgrastim
Every month we try and update this database with for pegfilgrastim cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma | NCT00499018 | Diffuse Large B... IPI≥2 | Rituximab Ciclofosfamide Doxorubicina Vincristina Prednisone Pegfilgrastim Mitoxantrone ARA-C Lenograstim BCNU ARA-C VP-16 ASCT Ciclofosfamide Doxorubicina Vincristina | 18 Years - 60 Years | Fondazione Italiana Linfomi - ETS | |
| Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer | NCT00569673 | Fallopian Tube ... Ovarian Cancer Primary Periton... | filgrastim pegfilgrastim docetaxel trabectedin | 18 Years - 120 Years | GOG Foundation | |
| Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma | NCT00101010 | Lymphoma | Filgrastim Pegfilgrastim Rituximab Cyclophosphamid... Pegylated lipos... Prednisone Vincristine Sul... | 61 Years - | M.D. Anderson Cancer Center | |
| Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer | NCT00063999 | Recurrent Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri... | Carboplatin Cisplatin Doxorubicin Hyd... Filgrastim Laboratory Biom... Paclitaxel Pegfilgrastim Quality-of-Life... | 18 Years - | GOG Foundation | |
| Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant. | NCT02909036 | Multiple Myelom... Amyloidosis | Melphalan Pegfilgrastim Autologous Hema... | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer | NCT00546377 | Leukemia Lymphoma | filgrastim pegfilgrastim rituximab sargramostim cyclophosphamid... mitoxantrone hy... pentostatin fluorescence in... gene rearrangem... polymerase chai... protein express... flow cytometry biopsy | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00107510 | Breast Cancer | pegfilgrastim carboplatin docetaxel conventional su... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma | NCT01879085 | Sarcoma | Docetaxel Gemcitabine Vorinostat Pegfilgrastim | 18 Years - | University of Pittsburgh | |
| Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer | NCT00346229 | Breast Cancer | filgrastim pegfilgrastim lyso-thermosens... hyperthermia tr... | 18 Years - | Duke University | |
| Pazopanib, Docetaxel, Prednisone Prostate | NCT01385228 | Prostate Cancer | Pazopanib Docetaxel Pazopanib Prednisone Pegfilgrastim | 18 Years - | Duke University | |
| Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas | NCT03220022 | AIDS-Related Ly... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... | Cyclophosphamid... Doxorubicin Hyd... Etoposide Filgrastim Ibrutinib Laboratory Biom... Pegfilgrastim Pharmacological... Prednisone Rituximab Vincristine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer | NCT04628767 | Renal Pelvis an... | Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Doxorubicin Hyd... Durvalumab Gemcitabine Hyd... Magnetic Resona... Methotrexate Pegfilgrastim Therapeutic Con... Vinblastine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer | NCT03639948 | Triple-negative... | Carboplatin Docetaxel Pembrolizumab Pegfilgrastim | 18 Years - 70 Years | University of Kansas Medical Center | |
| A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer | NCT00887536 | Breast Cancer | bevacizumab docetaxel doxorubicin cyclophosphamid... pegfilgrastim | 18 Years - 70 Years | NSABP Foundation Inc | |
| A Dose-Escalation Study for Patients With Advanced Cancer | NCT01214642 | Advanced Cancer | pegfilgrastim LY2523355 | 18 Years - | Eli Lilly and Company | |
| Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM | NCT00612989 | Glioblastoma Gliosarcoma | Temodar and O6-... | 18 Years - | Duke University | |
| Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer | NCT02412670 | High Grade Uppe... | Methotrexate Vinblastine Doxorubicin Cisplatin Gemcitabine Carboplatin Pegfilgrastim Nephroureterect... | 18 Years - | Eastern Cooperative Oncology Group | |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
| Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer | NCT00146562 | Breast Cancer Stage I Breast ... Stage II Breast... | Darbepoetin Alf... Pegfilgrastim Paclitaxel Doxorubicin Cyclophosphamid... | 18 Years - | Dana-Farber Cancer Institute | |
| Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP | NCT02983097 | Diffuse Large B... Follicular Lymp... Mantle Cell Lym... Burkitt Lymphom... Aggressive Marg... | Rituximab Cisplatin Carboplatin Dexamethasone Cytarabine Lenalidomide PegFilgrastim peripheral stem... | 18 Years - 70 Years | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | |
| Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma | NCT00278161 | Leukemia Lymphoma | Pegfilgrastim Rituximab Cyclophosphamid... | 18 Years - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | NCT00301925 | Breast Cancer | pegfilgrastim capecitabine cyclophosphamid... epirubicin hydr... fluorouracil methotrexate adjuvant therap... | 18 Years - 120 Years | Institute of Cancer Research, United Kingdom | |
| Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma | NCT00004192 | Lymphoma Neutropenia | filgrastim pegfilgrastim cisplatin cytarabine etoposide methylprednisol... | 18 Years - 120 Years | University of Nebraska | |
| Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma | NCT01639131 | Metastatic Colo... | Gemcitabine Docetaxel Filgrastim or P... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer | NCT04762901 | Breast Cancer | Niraparib Doxorubicin Cyclophosphamid... Paclitaxel Pegfilgrastim Carboplatin | 18 Years - | Wake Forest University Health Sciences | |
| TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors | NCT02650635 | Colorectal Aden... Metastatic Panc... Recurrent Breas... Recurrent Color... Recurrent Melan... Recurrent Non-S... Recurrent Pancr... Recurrent Renal... Solid Neoplasm Stage IV Breast... Stage IV Non-Sm... Stage IV Renal ... Stage IV Skin M... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... | Cyclophosphamid... Laboratory Biom... Pegfilgrastim Pharmacological... TLR8 Agonist VT... | 18 Years - | Mayo Clinic | |
| Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT05032183 | Recurrent Adult... Recurrent B Acu... Recurrent T Acu... Refractory B Ac... Refractory Lymp... Refractory T Ac... | Cyclophosphamid... Cytarabine Dexamethasone Filgrastim-sndz Leucovorin Mercaptopurine Mesna Methotrexate Pegfilgrastim Prednisone Rituximab Tagraxofusp-erz... Vincristine | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer | NCT04174742 | Breast | pegfilgrastim | 18 Years - | Wake Forest University Health Sciences | |
| Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma | NCT00067639 | Multiple Myelom... | Pegfilgrastim (... Apheresis | 18 Years - | M.D. Anderson Cancer Center | |
| Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT01256398 | Acute Lymphobla... Adult B Acute L... | Alemtuzumab Allogeneic Hema... Autologous Hema... Cyclophosphamid... Cytarabine Dasatinib Daunorubicin Hy... Dexamethasone Etoposide Phosp... Filgrastim Fludarabine Pho... In Vitro-Treate... Laboratory Biom... Leucovorin Calc... Melphalan Mercaptopurine Methotrexate Pegfilgrastim Pharmacological... Tacrolimus Vincristine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer | NCT00394251 | Breast Cancer | Adriamycin and ... ABI-007 Taxol Bevacizumab pegfilgrastim | 18 Years - 70 Years | Celgene | |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia | NCT00671658 | Leukemia Acute Lymphobla... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Dexamethasone Methotrexate (M... Cytarabine G-CSF Mesna Pegylated aspar... Pegfilgrastim Solumedrol | - | M.D. Anderson Cancer Center | |
| Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel | NCT01126190 | Chemotherapy-in... | Neugranin Pegfilgrastim Chemotherapy | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies | NCT02369458 | Squamous Cell C... Squamous Cell C... | Mitomycin-C Pegfilgrastim | 18 Years - | Washington University School of Medicine | |
| PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma | NCT00346125 | Sarcoma | pegfilgrastim doxorubicin hyd... ifosfamide pegylated lipos... conventional su... fludeoxyglucose... | 16 Years - | Masonic Cancer Center, University of Minnesota | |
| Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer | NCT00066443 | Breast Cancer | pegfilgrastim docetaxel epirubicin hydr... | 16 Years - | Canadian Cancer Trials Group | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | NCT00352118 | Head and Neck C... | filgrastim pegfilgrastim cisplatin docetaxel fluorouracil conventional su... radiation thera... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function | NCT00478361 | Distal Urethral... Metastatic Tran... Proximal Urethr... Recurrent Bladd... Recurrent Trans... Recurrent Ureth... Regional Transi... Stage III Bladd... Stage IV Bladde... Transitional Ce... Urethral Cancer... | Gemcitabine hyd... Paclitaxel Doxorubicin hyd... Pegfilgrastim | - | M.D. Anderson Cancer Center | |
| S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer | NCT00856492 | Breast Cancer | bevacizumab pegfilgrastim cyclophosphamid... doxorubicin hyd... paclitaxel albu... | 18 Years - | SWOG Cancer Research Network | |
| Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer | NCT00217529 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | pegfilgrastim carboplatin docetaxel erlotinib hydro... | 18 Years - | Fred Hutchinson Cancer Center | |
| A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma | NCT00117455 | Non-Hodgkin's L... | pegfilgrastim filgrastim | 18 Years - | Amgen | |
| LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer | NCT04762901 | Breast Cancer | Niraparib Doxorubicin Cyclophosphamid... Paclitaxel Pegfilgrastim Carboplatin | 18 Years - | Wake Forest University Health Sciences | |
| Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus | NCT00031629 | Recurrent Uteri... Uterine Corpus ... | Docetaxel Filgrastim Gemcitabine Hyd... Pegfilgrastim | 18 Years - | GOG Foundation | |
| Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma | NCT00670358 | Lymphoma | pegfilgrastim rituximab cyclophosphamid... doxorubicin hyd... lenalidomide prednisone vincristine sul... polymorphism an... laboratory biom... | 18 Years - 120 Years | Mayo Clinic | |
| Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma | NCT00808639 | Bladder Cancer Muscle-invasive... | Methotrexate Doxorubicin vinblastine cisplatin Pegfilgrastim | 18 Years - | Dana-Farber Cancer Institute | |
| Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain | NCT03407430 | Breast Cancer Lymphoma Pain | Pregabalin Placebo | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma | NCT01355705 | Multiple Myelom... | Amrubicin Lenalidomide Dexamethasone Aspirin Pegfilgrastim | 18 Years - | Stanford University | |
| Various G-CSF Regimens to Prevent Infection During Chemotherapy | NCT00536081 | Breast Cancer Chemotherapy Febrile Neutrop... | pegfilgrastim | 18 Years - | Academisch Ziekenhuis Maastricht | |
| Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer | NCT00030758 | Breast Cancer Neutropenia | filgrastim pegfilgrastim | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma | NCT00974792 | Lymphoma | pegfilgrastim rituximab cyclophosphamid... cytarabine doxorubicin hyd... etoposide phosp... ifosfamide leucovorin calc... methotrexate vincristine sul... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer | NCT00856492 | Breast Cancer | bevacizumab pegfilgrastim cyclophosphamid... doxorubicin hyd... paclitaxel albu... | 18 Years - | SWOG Cancer Research Network | |
| Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy | NCT00035620 | Sarcoma Neutropenia | pegfilgrastim filgrastim | - 21 Years | Amgen | |
| Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) | NCT00094822 | Lung Cancer Non-Small Cell ... | PI Discretion | 18 Years - | Amgen | |
| Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma | NCT00306111 | Non-Hodgkin Lym... | pegfilgrastim | 18 Years - | University Hospital Tuebingen | |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia | NCT03136146 | Recurrent Acute... Recurrent Adult... Recurrent Burki... Recurrent Burki... Recurrent Child... Recurrent High ... Refractory Acut... Refractory Burk... Refractory Burk... Refractory High... Refractory Lymp... | Bortezomib Clofarabine Cyclophosphamid... Dexamethasone Etoposide Ofatumumab Pegfilgrastim Rituximab Vincristine Sul... | 15 Years - | M.D. Anderson Cancer Center | |
| Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain | NCT03407430 | Breast Cancer Lymphoma Pain | Pregabalin Placebo | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma | NCT00067639 | Multiple Myelom... | Pegfilgrastim (... Apheresis | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | NCT00301925 | Breast Cancer | pegfilgrastim capecitabine cyclophosphamid... epirubicin hydr... fluorouracil methotrexate adjuvant therap... | 18 Years - 120 Years | Institute of Cancer Research, United Kingdom | |
| Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma | NCT00115193 | Non-Hodgkin's L... | pegfilgrastim pegfilgrastim | 18 Years - | Amgen | |
| Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors | NCT00551122 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel | 16 Years - 60 Years | University of Southampton | |
| Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer | NCT00404066 | Breast Cancer Metastatic Brea... | Lapatinib Doxorubicin Cyclophosphamid... Docetaxel Pegfilgrastim Filgrastim Dexamethasone Trastuzumab | 18 Years - 70 Years | Stanford University | |
| Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | NCT01847001 | Locally Advance... Breast Cancer | Propranolol DOT imaging Paclitaxel Nab-paclitaxel Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Surgery Premedication Anti-nausea the... Pegfilgrastim | 18 Years - | Columbia University | |
| Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors | NCT01654965 | Adult Solid Neo... | Laboratory Biom... Pegfilgrastim Pharmacological... Tivantinib Topotecan Hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer | NCT00352300 | Fallopian Tube ... Infectious Diso... Neutropenia Ovarian Carcino... Primary Periton... Stage III Ovari... Stage IV Ovaria... | Adjuvant Therap... Carboplatin Paclitaxel Pegfilgrastim | 18 Years - | GOG Foundation | |
| Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus | NCT00031629 | Recurrent Uteri... Uterine Corpus ... | Docetaxel Filgrastim Gemcitabine Hyd... Pegfilgrastim | 18 Years - | GOG Foundation | |
| Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | NCT01847001 | Locally Advance... Breast Cancer | Propranolol DOT imaging Paclitaxel Nab-paclitaxel Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Surgery Premedication Anti-nausea the... Pegfilgrastim | 18 Years - | Columbia University | |
| Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor | NCT00304070 | Stage I Adrenal... Stage II Adrena... Stage III Adren... Stage IV Adrena... | Cisplatin Conventional Su... Doxorubicin Hyd... Etoposide Filgrastim Mitotane Pegfilgrastim | - 21 Years | Children's Oncology Group | |
| An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) | NCT02782845 | Non-Hodgkin's L... | Chemotherapy Immunochemother... Pegfilgrastim | 18 Years - 65 Years | Hoffmann-La Roche | |
| Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel | NCT00837265 | Chemotherapy-in... | Balugrastim Pegfilgrastim Chemotherapy Re... | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia | NCT03214562 | High Risk Myelo... Recurrent Acute... Refractory Acut... | Cytarabine Filgrastim Fludarabine Idarubicin Pegfilgrastim Venetoclax | 18 Years - | M.D. Anderson Cancer Center | |
| Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma | NCT01313884 | Bone Cancer Ewing's Sarcoma | Irinotecan Vincristine Temozolomide Doxorubicin Cytoxan Pegfilgrastim | 13 Years - | Stanford University | |
| Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma | NCT04156828 | Grade 3b Follic... Recurrent Diffu... Recurrent Folli... Refractory Diff... Non-Hodgkin's L... | Copanlisib Gemcitabine Carboplatin Dexamethasone Rituximab Pegfilgrastim | 18 Years - | University of Washington | |
| FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer | NCT05011188 | Metastatic Cast... Prostate Cancer | FOR46 Enzalutamide Pegfilgrastim | 18 Years - | University of California, San Francisco | |
| LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer | NCT04762901 | Breast Cancer | Niraparib Doxorubicin Cyclophosphamid... Paclitaxel Pegfilgrastim Carboplatin | 18 Years - | Wake Forest University Health Sciences | |
| Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim | NCT00280787 | Non Small Cell ... | Paclitaxel Carboplatin CPT-11 Pegfilgrastim Conformal radio... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00077311 | Anemia Drug/Agent Toxi... Lung Cancer Neutropenia | darbepoetin alf... pegfilgrastim cisplatin docetaxel BNP7787 | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma | NCT00004192 | Lymphoma Neutropenia | filgrastim pegfilgrastim cisplatin cytarabine etoposide methylprednisol... | 18 Years - 120 Years | University of Nebraska | |
| Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer | NCT01498588 | Breast Neoplasm... Breast Cancer Breast Tumors Cancer of the B... Neoplasms, Brea... Tumors, Breast | Eribulin Doxorubicin Cyclophosphamid... Pegfilgrastim | 18 Years - | Emory University | |
| Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 | NCT03102606 | Chemotherapy-in... | Plinabulin Pegfilgrastim Saline Placebo D5W Placebo | 18 Years - | BeyondSpring Pharmaceuticals Inc. | |
| Split-Dose R-CHOP for Older Adults With DLBCL | NCT03943901 | Diffuse Large B... DLBCL Cancer | Rituximab Cyclophosphamid... Doxorubicin Vincristine Prednisone Pegfilgrastim | 70 Years - | University of Wisconsin, Madison |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
